In the absence of head-to-head randomized trials, investigators performed a network meta-analysis to compared drugs for post-transplant diabetes.

Two newly approved medications expand options beyond lifestyle modifications for metabolic dysfunction-associated steatotic ...

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Doctors and life-science companies are looking for alternative approaches to the treatment of type 1 diabetes (T1D) ...

Abu Dhabi is pioneering AI-driven healthcare, launching initiatives like the Next-Gen Wellness program to predict and prevent ...

Genetic screening can mean that people at risk of type 1 diabetes get earlier treatment and better outcomes This article is ...

Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate ...

Shifting to a high-fibre diet can prevent, and even reverse, a common liver disease caused by dietary fructose, a new study ...

Novo Nordisk acquires Akero Therapeutics to enhance its portfolio with efruxifermin, a promising treatment for metabolic ...

A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib safely preserved the body's own insulin production ...

A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy.